 Aimmune Therapeutics, Inc. NASDAQ:AIMT Q2 2020 Earnings Conference Call July 30, 2020, 16:30 ET Company Participants DeDe Sheel - VP, IR Jayson Dallas - President, CEO Director Daniel Adelman - Chief Medical Officer Andrew Oxtoby - Chief Commercial Officer Eric Bjerkholt - CFO Conference Call Participants Vasiliana Moussatos - Wedbush Securities Christopher Raymond - Piper Sandler Co. 